ArticleOncogene2008

P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.

F Toscano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.